SEC Charges Former CEO of Biotech Company CytoDyn with Fraud, Insider Trading
The Securities and Exchange Commission today charged Nader Pourhassan, the former CEO of CytoDyn Inc., with fraud and insider trading in connection with providing misleading information to shareholders about the progress of a clinical research treatment…
Read the Full Press Release
Have a securities law question? Call New York Securities Lawyers at 212-509-6544.